+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?

Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?

Journal of Infectious Diseases 211(1): 72-79

Infective endocarditis (IE) mostly occurs after spontaneous low-grade bacteremia. Thus, IE cannot be prevented by circumstantial antibiotic prophylaxis. Platelet activation following bacterial-fibrinogen interaction or thrombin-mediated fibrinogen-fibrin polymerization is a critical step in vegetation formation. We tested the efficacy of antiplatelet and antithrombin to prevent experimental IE. A rat model of experimental IE following prolonged low-grade bacteremia mimicking smoldering bacteremia in humans was used. Prophylaxis with antiplatelets (aspirin, ticlopidine [alone or in combination], eptifibatide, or abciximab) or anticoagulants (antithrombin dabigatran etexilate or anti-vitamin K acenocoumarol) was started 2 days before inoculation with Streptococcus gordonii or Staphylococcus aureus. Valve infection was assessed 24 hours later. Aspirin plus ticlopidine, as well as abciximab, protected 45%-88% of animals against S. gordonii and S. aureus IE (P < .05). Dabigatran etexilate protected 75% of rats against IE due to S. aureus (P < .005) but failed to protect against S. gordonii (<30% protection). Acenocoumarol was ineffective. Antiplatelet and direct antithrombin agents may be useful in the prophylaxis of IE in humans. In particular, the potential dual benefit of dabigatran etexilate might be reconsidered for patients with prosthetic valves, who require life-long anticoagulation and in whom S. aureus IE is associated with high mortality.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 055232366

Download citation: RISBibTeXText

PMID: 25086177

DOI: 10.1093/infdis/jiu426

Related references

The prevention of infective endocarditis toward a surprising paradigm: antibiotic prophylaxis restricted to patients at risk of endocarditis with poor outcome. Giornale Italiano di Cardiologia 10(6): 382-394, 2009

Role of aspirin in the prevention of embolism in infective endocarditis Rationale, design and feasibility data of the Canadian Aspirin Trial in infective endocarditis. Circulation 90(4 Part 2): I121, 1994

Infective endocarditis: what's new? European Society of Cardiology (ESC) Guidelines 2009 on the prevention, diagnosis and treatment of infective endocarditis. Presse Medicale 39(6): 704-709, 2010

Acute Aortic Valve Rupture From Infective Endocarditis After Transrectal Prostate Biopsy: A Call to Revise the AHA Guidelines for Prevention of Infective Endocarditis. Clinical Medicine Insights. Case Reports 6: 29-33, 2013

Comparison of characteristics and short-term outcome from fungal infective endocarditis in prosthetic valve endocarditis versus native valve endocarditis. American Journal of Cardiology 112(1): 111-116, 2013

Prophylaxis for the prevention of infective endocarditis. Medical Journal of Australia 160(7): 453, 1994

Infective endocarditis--prophylaxis and prevention. Dental Update 10(4): 254-258, 1983

Prophylaxis for the Prevention of Infective Endocarditis. Australian Dental Journal 38(2): 154-156, 1993

Infective endocarditis prophylaxis: moving from dental prophylaxis to global prevention?. European Journal of Clinical Microbiology and Infectious Diseases 31(9): 2089-2095, 2012

Antibiotic prophylaxis of infective endocarditis. Recommendations from the Endocarditis Working Party of the British Society for Antimicrobial Chemotherapy. Lancet 335(8681): 88-89, 1990

Antimicrobial prophylaxis for the prevention of infective endocarditis. British Journal of Hospital Medicine 72(6): 336-340, 2011

Current prophylaxis for prevention of infective endocarditis. British Dental Journal 168(10): 409-410, 1990

Antibiotic prophylaxis for the prevention of infective endocarditis. Harefuah 119(9): 275-277, 1990

Is the antibiotic prophylaxis necessary for the prevention of infective endocarditis?. Semergen 41(8): 446-447, 2016

Prophylaxis of infective endocarditis: prevention of the perfect storm. International Journal of Antimicrobial Agents 30(Suppl. 1): S37-S41, 2007